Nuveen Asset Management LLC lessened its holdings in shares of NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating) by 23.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 633,157 shares of the company's stock after selling 198,309 shares during the period. Nuveen Asset Management LLC owned approximately 0.94% of NextGen Healthcare worth $11,207,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of NXGN. Clearstead Advisors LLC bought a new position in shares of NextGen Healthcare during the 2nd quarter valued at about $26,000. Truvestments Capital LLC bought a new stake in NextGen Healthcare in the 2nd quarter valued at approximately $77,000. Captrust Financial Advisors lifted its stake in NextGen Healthcare by 61.5% in the 1st quarter. Captrust Financial Advisors now owns 4,255 shares of the company's stock valued at $89,000 after acquiring an additional 1,620 shares in the last quarter. UBS Group AG lifted its stake in NextGen Healthcare by 211.1% in the 3rd quarter. UBS Group AG now owns 6,639 shares of the company's stock valued at $118,000 after acquiring an additional 4,505 shares in the last quarter. Finally, DCM Advisors LLC bought a new stake in NextGen Healthcare in the 2nd quarter valued at approximately $183,000. Institutional investors own 73.70% of the company's stock.
Get NextGen Healthcare alerts:NextGen Healthcare Trading Down 1.1 %
Shares of NextGen Healthcare stock opened at $17.65 on Thursday. NextGen Healthcare, Inc. has a 12-month low of $16.13 and a 12-month high of $21.99. The stock has a market cap of $1.17 billion, a P/E ratio of 50.43 and a beta of 1.03. The company has a quick ratio of 2.53, a current ratio of 2.53 and a debt-to-equity ratio of 0.64. The business's 50 day moving average is $18.34 and its 200-day moving average is $18.50.
Analyst Upgrades and Downgrades
Separately, StockNews.com cut NextGen Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Friday, January 20th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, NextGen Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $22.75.
NextGen Healthcare Profile
(Get Rating)
NextGen Healthcare, Inc provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange.
Read More
- Get a free copy of the StockNews.com research report on NextGen Healthcare (NXGN)
- META Platforms May See its Biggest Opening Yet for New Highs
- Penny Stock Vinco Ventures Could Be Big Winner
- Is Chip Design Specialist Synopsys A Gem Hiding In Plain Sight?
- Should You Park Some Capital with Casey's General Stores?
- Crowdstrike Stock: While The Iron Is Hot!
Want to see what other hedge funds are holding NXGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating).
Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.